Bronhopulmonalna displazija

Abstract

Bronchopulmonary dysplasia (BDP) is a chronic lung disease which is defined as the need to apply oxygen therapy 28 days of postnatal life and the degree of severity of the disease is determined 36 weeks corrected gestational age (KGS). It is a chronic lung disease whose symptoms and signs are derived from the neonatal period and is one of the most severe consequences of preterm labor, leading to extended and fixed depending on the application and oxygen influences the mortality and morbidity in preterm infants. The pathological process in pulmonary hemorrhage and affects the airways and lung parenchyma and usually occurs in small premature infants with respiratory distress syndrome which leads to lung injury and inadequate reparations such damage. Frequency of GDP ranges from 4-53%. Risk factors for the development of bronchopulmonary dysplasia can be podlijediliti on prenatal and postnatal. The criteria for determining the severity of BPD vary for infants who are born before or after 32 gestational weeks. Given that the GDP chronic lung disease can last for weeks and months but they certainly need to be patient and not expect rapid improvement after therapy administered.